. Author manuscript; available in PMC: 2009 Feb 20.

Published in final edited form as: J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):957–962. doi: 10.1093/gerona/61.9.957

Table 2.

Adjusted Risk for 5-Year Mortality by DHEAS Quartile

Hazard Ratio	1st Quartile	2nd Quartile	3rd Quartile	4th Quartile
Age-adjusted (95% CI)	1.82 (1.16–2.87)^*	1.13 (0.67–1.90)	1.0 (Reference)	1.58 (0.88–2.84)
Multivariate-adjusted (95% CI)^‡	2.05 (1.27–3.32)^*	1.18 (0.69–2.02)	1.0 (Reference)	2.15 (1.17–3.98)^†

Notes: p < .01 vs reference group.

^†

p < .05 vs reference group.

^‡

Adjusted for age, education, race, smoking status, body mass index, estrogen use, corticosteroid use, chronic conditions including coronary heart disease, congestive heart failure, peripheral artery disease, hip fracture, osteoarthritis, rheumatoid arthritis, diabetes mellitus, cancer, stroke, and chronic obstructive pulmonary disease.

DHEAS = dehydroepiandrosterone sulfate; CI = confidence interval.